Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection

Lars Steinstraesser, Tobias Hirsch, Matthias Schulte, Maximilian Kueckelhaus, Frank Jacobsen, Evgeniija A. Mersch, Ingo Stricker, Nicole Afacan, Håvard Jenssen, Robert E. W. Hancock, Jason Kindrachuck

    Research output: Contribution to journalJournal articleResearchpeer-review

    Abstract

    Innate defense regulators (IDRs) are synthetic immunomodulatory versions of natural host defense peptides (HDP). IDRs mediate protection against bacterial challenge in the absence of direct antimicrobial activity, representing a novel approach to anti-infective and anti-inflammatory therapy. Previously, we reported that IDR-1018 selectively induced chemokine responses and suppressed pro-inflammatory responses. As there has been an increasing appreciation for the ability of HDPs to modulate complex immune processes, including wound healing, we characterized the wound healing activities of IDR-1018 in vitro. Further, we investigated the efficacy of IDR-1018 in diabetic and non-diabetic wound healing models. In all experiments, IDR-1018 was compared to the human HDP LL-37 and HDP-derived wound healing peptide HB-107. IDR-1018 was significantly less cytotoxic in vitro as compared to either LL-37 or HB-107. Furthermore, administration of IDR-1018 resulted in a dose-dependent increase in fibroblast cellular respiration. In vivo, IDR-1018 demonstrated significantly accelerated wound healing in S. aureus infected porcine and non-diabetic but not in diabetic murine wounds. However, no significant differences in bacterial colonization were observed. Our investigation demonstrates that in addition to previously reported immunomodulatory activities IDR-1018 promotes wound healing independent of direct antibacterial activity. Interestingly, these effects were not observed in diabetic wounds. It is anticipated that the wound healing activities of IDR-1018 can be attributed to modulation of host immune pathways that are suppressed in diabetic wounds and provide further evidence of the multiple immunomodulatory activities of IDR-1018.
    Original languageEnglish
    JournalP L o S One
    Volume7
    Issue number8
    ISSN1932-6203
    DOIs
    Publication statusPublished - 2012

    Cite this

    Steinstraesser, L., Hirsch, T., Schulte, M., Kueckelhaus, M., Jacobsen, F., Mersch, E. A., Stricker, I., Afacan, N., Jenssen, H., Hancock, R. E. W., & Kindrachuck, J. (2012). Innate Defense Regulator Peptide 1018 in Wound Healing and Wound Infection. P L o S One, 7(8). https://doi.org/10.1371/journal.pone.0039373